Patent · US Active

Pyridin-2-one compounds and their use as modulators of the dopamine D3 receptor

US7960386B2 · kind B2 · utility

1Cited by

3References

12Claims

0Family size

Assignee

Abbott GmbH & Co. KG · DE

Inventors

Hervé Geneste · Schifferstadt, DE
Wilfried Braje · Ludwigshafen, DE
Andreas Haupt · Ludwigshafen, DE

Key dates

Filing date	Jun 3, 2005
Grant date	Jun 14, 2011
Priority date	—
Expiry date	Aug 29, 2027

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to pyridin-2-one compounds of general formula (I)in which The invention also relates to the tautomers of compounds I and the physiologically acceptable salts of the compounds I and their tautomers.The invention also relates to the use of these compounds for treating diseases that respond to the influence of dopamine D3 receptor antagonists or agonists.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.